Cardiac steatosis associates with visceral obesity in nondiabetic obese men.

BACKGROUND Liver fat and visceral adiposity are involved in the development of the metabolic syndrome (MetS). Ectopic fat accumulation within and around the heart has been related to increased risk of heart disease. The aim of this study was to explore components of cardiac steatosis and their relationship to intra-abdominal ectopic fat deposits and cardiometabolic risk factors in nondiabetic obese men. METHODS Myocardial and hepatic triglyceride (TG) contents were measured with 1.5 T magnetic resonance spectroscopy, and visceral adipose (VAT), abdominal subcutaneous tissue (SAT), epicardial and pericardial fat by magnetic resonance imaging in 37 men with the MetS and in 40 men without the MetS. RESULTS Myocardial and hepatic TG contents, VAT, SAT, epicardial fat volumes, and pericardial fat volumes were higher in men with the MetS compared with subjects without the MetS (P < .001). All components of cardiac steatosis correlated with SAT, VAT, and hepatic TG content and the correlations seemed to be strongest with VAT. Myocardial TG content, epicardial fat, pericardial fat, VAT, and hepatic TG content correlated with waist circumference, body mass index, high-density lipoprotein cholesterol TGs, very low-density lipoprotein-1 TGs, and the insulin-resistance homeostasis model assessment index. VAT was a predictor of TGs, high-density lipoprotein cholesterol, and measures of glucose metabolism, whereas age and SAT were determinants of blood pressure parameters. CONCLUSIONS We suggest that visceral obesity is the best predictor of epicardial and pericardial fat in abdominally obese subjects. Myocardial TG content may present a separate entity that is influenced by factors beyond visceral adiposity.

[1]  E. Abel,et al.  Lipotoxicity in the heart. , 2010, Biochimica et biophysica acta.

[2]  Benjamin D. Levine,et al.  Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study , 2007, Circulation.

[3]  S. Grundy,et al.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.

[4]  J. Borén,et al.  The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction. , 2011, The Journal of clinical investigation.

[5]  P. Kellman,et al.  Myocardial Fat Imaging , 2010, Current cardiovascular imaging reports.

[6]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[7]  J. Levy,et al.  Use and abuse of HOMA modeling. , 2004, Diabetes care.

[8]  P. Iozzo,et al.  Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. , 2006, The Journal of clinical endocrinology and metabolism.

[9]  G. Shulman,et al.  Chylomicron- and VLDL-derived Lipids Enter the Heart through Different Pathways , 2010, The Journal of Biological Chemistry.

[10]  R. de Beer,et al.  Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals , 2001, Comput. Biol. Medicine.

[11]  N. Lundbom,et al.  Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. , 2009, Gastroenterology.

[12]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[13]  Vanhamme,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[14]  P. Schrauwen,et al.  Lipotoxicity in type 2 diabetic cardiomyopathy. , 2011, Cardiovascular research.

[15]  G. Metzger,et al.  Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging , 2003, Magnetic resonance in medicine.

[16]  Thomas D. Giles,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Jean-PierreDesprés.  Body Fat Distribution and Risk of Cardiovascular Disease , 2012 .

[18]  Lawrence Joseph,et al.  The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[19]  K. Clément,et al.  Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat , 2012, International Journal of Obesity.

[20]  Paul Poirier,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2006, Circulation.

[21]  M. Shimabukuro.  Cardiac adiposity and global cardiometabolic risk: new concept and clinical implication. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[22]  Eugenio Picano,et al.  Pericardial rather than epicardial fat is a cardiometabolic risk marker: an MRI vs echo study. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[23]  Patricia Iozzo,et al.  Myocardial, Perivascular, and Epicardial Fat , 2011, Diabetes Care.

[24]  G. Iacobellis,et al.  Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features , 2011, Trends in Endocrinology & Metabolism.

[25]  M. Roden,et al.  Ectopic lipids and organ function , 2009, Current opinion in lipidology.

[26]  R. Eckel,et al.  Prevention of Overweight/Obesity as a Strategy to Optimize Cardiovascular Health , 2011, Circulation.

[27]  J. Murabito,et al.  The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk , 2012, Diabetologia.

[28]  S. Grundy,et al.  The metabolic syndrome , 2003, The Lancet.

[29]  Petra C. Kienesberger,et al.  Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. , 2010, American journal of physiology. Endocrinology and metabolism.

[30]  D. Bluemke,et al.  Myocardial fat quantification in humans: Evaluation by two‐point water‐fat imaging and localized proton spectroscopy , 2010, Magnetic resonance in medicine.

[31]  Jeroen J. Bax,et al.  Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. , 2008, Journal of the American College of Cardiology.

[32]  Philippe Pibarot,et al.  Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[33]  A. Häkkinen,et al.  Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk , 2004, Diabetologia.

[34]  Paul Schoenhagen,et al.  The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. , 2010, Archives of internal medicine.

[35]  J. Després,et al.  Body Fat Distribution and Risk of Cardiovascular Disease: An Update , 2012, Circulation.

[36]  P. Iozzo,et al.  Contribution of glucose tolerance and gender to cardiac adiposity. , 2009, The Journal of clinical endocrinology and metabolism.

[37]  J. Schulz-Menger,et al.  Myocardial steatosis, cardiac remodelling and fitness in insulin-sensitive and insulin-resistant obese women , 2011, Heart.

[38]  A. Häkkinen,et al.  Overproduction of large VLDL particles is driven by increased liver fat content in man , 2006, Diabetologia.

[39]  S. Daniels,et al.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.

[40]  L. Orci,et al.  Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. , 2007, Circulation research.

[41]  Salim Yusuf,et al.  Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries. , 2010, Journal of the American College of Cardiology.